Literature DB >> 35474712

"A cohort of pirate ships": biomedical citizen scientists' attitudes toward ethical oversight.

Meredith Trejo1, Isabel Canfield1, Whitney Bash Brooks1, Alex Pearlman2, Christi J Guerrini1.   

Abstract

As biomedical citizen science initiatives become more prevalent, the unique ethical issues that they raise are attracting policy attention. The ethical oversight of bottom-up biomedical citizen science projects that are designed and executed primarily or solely by members of the public is a significant concern because the federal rules that require ethical oversight of research by institutional review boards generally do not apply to such projects, creating what has been called an ethics gap. Working to close this gap, practitioners and scholars have considered new mechanisms of ethical oversight for biomedical citizen science. To date, however, participants' attitudes about ethics and oversight preferences have not been systematically examined. This information is useful to efforts to develop ethical oversight mechanisms because it provides a basis for evaluating the likely effectiveness of specific features of such mechanisms and their acceptability from the perspective of biomedical citizen scientists. Here, we report data from qualitative interviews with 35 stakeholders in bottom-up biomedical citizen science about their general ethics attitudes and preferences regarding ethical oversight. Interviewees described ten ethical priorities and endorsed oversight mechanisms that are voluntary, community-driven, and offer guidance. Conversely, interviewees rejected mechanisms that are mandatory, hierarchical, and inflexible. Applying these findings, we conclude that expert consultation and community review models appear to align well with ethical priorities and oversight preferences of many biomedical citizen scientists, although local conditions should guide the development and use of mechanisms in specific communities.

Entities:  

Year:  2021        PMID: 35474712      PMCID: PMC9037960          DOI: 10.5334/cstp.360

Source DB:  PubMed          Journal:  Citiz Sci        ISSN: 2057-4991


  21 in total

1.  Community-based participatory research and the ethics review process.

Authors:  Nancy Shore
Journal:  J Empir Res Hum Res Ethics       Date:  2007-03       Impact factor: 1.742

2.  The ethics of participant-led biomedical research.

Authors:  Effy Vayena; John Tasioulas
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908

3.  The Rise of Citizen Science in Health and Biomedical Research.

Authors:  Andrea Wiggins; John Wilbanks
Journal:  Am J Bioeth       Date:  2019-08       Impact factor: 11.229

4.  Making it Easier to Make Your Own IRB.

Authors:  Christopher Santos-Lang
Journal:  Narrat Inq Bioeth       Date:  2019

5.  Beyond Belmont-and Beyond Regulations.

Authors:  Lisa M Rasmussen
Journal:  Am J Bioeth       Date:  2019-08       Impact factor: 11.229

6.  Balancing Benefits and Risks of Immortal Data: Participants' Views of Open Consent in the Personal Genome Project.

Authors:  Oscar A Zarate; Julia Green Brody; Phil Brown; Mónica D Ramirez-Andreotta; Laura Perovich; Jacob Matz
Journal:  Hastings Cent Rep       Date:  2015-12-17       Impact factor: 2.683

7.  How Biomedical Citizen Scientists Define What They Do: It's All in the Name.

Authors:  Meredith Trejo; Isabel Canfield; Jill O Robinson; Christi J Guerrini
Journal:  AJOB Empir Bioeth       Date:  2020-09-29

8.  The Social Context of "Do-It-Yourself" Brain Stimulation: Neurohackers, Biohackers, and Lifehackers.

Authors:  Anna Wexler
Journal:  Front Hum Neurosci       Date:  2017-05-10       Impact factor: 3.169

9.  Approaches to governance of participant-led research: a qualitative case study.

Authors:  Azure Dominique Grant; Gary Isaac Wolf; Camille Nebeker
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

10.  openSNP--a crowdsourced web resource for personal genomics.

Authors:  Bastian Greshake; Philipp E Bayer; Helge Rausch; Julia Reda
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.